Overview of the Skin Microbiome in Health

The human skin microbiome comprises a diverse community of bacteria, fungi, viruses, and mites, whose collective genomic content – known as the skin microbiome – plays a pivotal role in maintaining cutaneous homeostasis. The composition of the microbiome is influenced by anatomical site, sebaceous activity, host genetics, immune status, and environmental exposures [1]. Sebaceous regions such as the face, chest, and back harbor lipophilic organisms, with Cutibacterium acnes being one of the predominant bacterial species [1,6].

In healthy individuals, C. acnes exists as a mutualistic commensal, contributing to skin health through sebum metabolism [6], competitive inhibition of pathogenic bacteria [16], and modulation of local immune responses [16]. However, when environmental or host factors disrupt this balanced relationship, certain C. acnes strains can adopt pathogenic behaviors, driving inflammation and acne lesion formation [5,6].

Strain-Level Diversity of C. acnes and Its Clinical Significance

Cutibacterium acnes is not a monolithic species. Phylogenetic analyses have identified several major lineages – IA1, IA2, IB, IC, II, and III – with strain-level variation influencing pathogenic potential [5,6,22].

This heterogeneity has crucial therapeutic implications: rather than eradicating C. acnes wholesale, interventions that selectively target acne-associated phylotypes could resolve inflammation while preserving protective strains [5,6,12]. Bacteriophages – by virtue of their strain specificity – are well-suited to this task [6,14,21].

Athletic Training as a Driver of Skin Microbiome Perturbation

Athletic activities impose unique stresses on the skin, creating an environment conducive to dysbiosis [2–4]. The following factors are particularly relevant:

Frequent cleansing and barrier disruption

Athletes often shower multiple times daily, frequently using high-pH or antimicrobial soaps [2,3]. While intended to maintain hygiene, such practices can strip the lipid barrier and alter microbial diversity [1], potentially reducing the abundance of commensal Staphylococcus epidermidis and Corynebacterium spp., which normally compete with C. acnes for ecological niches [1,16].

Differences between acne in athletes and general population was described in Table 1.

Table 1: Differences between acne in athletes and general population.

Clinical Patterns of Acne in Athletes

Sports-related acne in athletes can present in patterns that reflect the mechanical and environmental stresses of training.

In many cases, these presentations represent an interplay between mechanical triggers and microbial shifts, with C. acnes dysbiosis acting as a central pathogenic driver [2–6].

Evidence for Dysbiosis in Athletes

While specific large-scale microbiome studies in athletes remain limited, available data suggest that intense physical activity can alter both the diversity and functional potential of skin microbial communities [2–6]. Metagenomic analyses have shown:

Experimental models have demonstrated that heat and humidity can enhance C. acnes biofilm formation within follicles [3,15], increasing resistance to topical antimicrobials [15]. Biofilm-associated C. acnes strains may also produce higher levels of porphyrins, which contribute to oxidative stress in the follicular environment [5,6,23].

Why Targeted Microbiome Modulation is Attractive for Athletes

Given the above, therapeutic strategies that can selectively reduce inflammatory C. acnes strains while preserving overall skin microbial diversity are of particular interest in sports medicine [5,6,12,19]. Overly broad-spectrum approaches risk undermining the skin’s natural defense mechanisms, leading to:

Bacteriophage therapy, with its precision targeting, represents a logical extension of these principles [6,13,12,14,18,21]. Rather than relying on chemical agents to non-selectively kill bacteria, phages can be selected or engineered to bind to specific receptors on pathogenic C. acnes strains, sparing those with beneficial or neutral roles [6,14,21].

Interactions with the Athlete’s Immune System

Athletes often experience immune fluctuations due to high training loads, including transient immunosuppression after prolonged endurance events and shifts in cytokine profiles associated with intense anaerobic training [2–4]. These immune variations may influence acne pathogenesis by altering inflammatory thresholds in the skin [5,6]. Dysbiosis, particularly when dominated by pro-inflammatory C. acnes strains, can act synergistically with such immune changes to promote more severe or persistent acne lesions [2–6]. Targeted modulation of the microbiome could, therefore, play a role not only in reducing bacterial burden but also in stabilizing cutaneous immune responses [6,12,14,21].

In summary, C. acnes dysbiosis in athletes is driven by a combination of environmental stressors, mechanical factors, and host immune modulation [2–6]. It differs in both trigger profile and clinical presentation from acne in the general population [1,2]. This specificity underscores the need for tailored approaches such as bacteriophage therapy that can address the unique pathophysiological landscape of acne in sports settings [6,12,13,19].

Fundamental Biology of Bacteriophages

Bacteriophages (phages) are viruses that specifically infect and replicate within bacterial hosts [8,18,21]. They are the most abundant biological entities on Earth, with an estimated 10³¹ particles globally [18]. Phages exhibit remarkable diversity in morphology, genetic content, and host specificity. Taxonomically, they are classified into various families, including Siphoviridae, Myoviridae, and Podoviridae, which differ primarily in tail structure and genome organization [18,21].

Phages relevant to dermatology – particularly those targeting Cutibacterium acnes – belong predominantly to the Siphoviridae family [14,21]. These are double-stranded DNA viruses characterized by long, non-contractile tails, which they use to attach to specific receptors on the bacterial surface [14]. The specificity of phage–host interaction is determined by tail fiber proteins that recognize unique bacterial cell wall or membrane components [14,21].

Lytic versus Lysogenic Life Cycles

Phages employ two main life cycles [18,21]:

All C. acnes phages isolated to date appear to be strictly lytic [14,21], which enhances their suitability as therapeutic agents.

Host Specificity and Co-evolutionary Dynamics

One of the most compelling features of bacteriophages is their narrow host range. A given phage may infect only a single bacterial species – or even specific strains within that species [14,21]. This specificity is mediated by receptor-binding proteins that fit like a molecular “lock-and-key” with bacterial surface receptors [14]. In the context of C. acnes, this means that phages can be selected to target pathogenic phylotypes, such as IA1 strains, while leaving beneficial or neutral phylotypes intact [5,6,14].

However, the relationship between phages and bacteria is dynamic [18,21]. Bacteria can evolve resistance through receptor modification, CRISPR-Cas immune systems, or other mechanisms. In turn, phages adapt through mutations in tail fiber proteins or by acquiring new genetic modules [21]. This evolutionary “arms race” has therapeutic implications, suggesting that phage cocktails containing multiple complementary phages may be more effective in maintaining long-term efficacy than monotherapy [18,19,21].

C. acnes Phages: Discovery and Characterization

Phages infecting C. acnes were first reported in the 1960s [13,14]. Renewed interest in the past two decades has led to genomic sequencing of multiple C. acnes phages [14,17,21,22], revealing relatively conserved genomes of approximately 29–31 kilobases, with high similarity between isolates from geographically diverse populations. This genomic homogeneity is unusual compared to phages of other bacterial species and may reflect the relatively uniform ecological niche of C. acnes within human sebaceous follicles [14,22].

Functionally, C. acnes phages have been shown to efficiently lyse their hosts in vitro [14,21], including antibiotic-resistant strains [14,17]. They are also capable of disrupting C. acnes biofilms [15], a significant advantage as biofilm-associated bacteria are more resistant to conventional antibiotics and topical agents [15].

Advantages of Phage Therapy over Conventional Acne Treatments

Compatibility with anti-doping regulations

As naturally occurring biological agents without performance-enhancing properties [11,19], phages are unlikely to be restricted under anti-doping guidelines [11] – although formal clearance from regulatory bodies would be necessary for elite competition [19].

Advantages of bacteriophage therapy over conventional acne treatments was described in Table 2.

Table 2: Advantages of bacteriophage therapy over conventional acne treatments.

Preclinical and Early Clinical Evidence

In vitro studies have consistently demonstrated that C. acnes-specific phages can significantly reduce bacterial counts within hours of application. Animal models, though limited for acne research due to species-specific colonization patterns, have shown reduced inflammation and lesion formation following topical or intradermal phage administration [12,14,21].

Human studies are still in early stages. A pilot randomized trial involving 60 participants with mild-to-moderate acne reported that a topical gel containing a C. acnes phage cocktail reduced inflammatory lesion counts by approximately 45% over 8 weeks, with minimal adverse effects [12,13,20]. Importantly, post-treatment skin swabs showed preservation of commensal microbial diversity compared to baseline [6,16].

Delivery Systems for Dermatologic Phage Therapy

The therapeutic success of phages depends not only on their lytic activity but also on their stability and delivery to the target site [18–20]. For acne, this means penetrating the pilosebaceous unit while maintaining phage viability in the presence of sebum, sweat, and variable pH [18,19].

Topical formulations have received the most attention:

Innovations in microencapsulation and nanocarrier systems are also being explored to shield phages from environmental stressors and control their release over time [18–20].

Safety Considerations

Phages are generally considered safe for human use, given their long-standing co-existence with the human microbiome and their inability to infect eukaryotic cells [8,18,19,21]. Nonetheless, therapeutic candidates must be thoroughly screened to ensure:

Topical application further reduces systemic exposure, but allergic reactions to formulation excipients remain a consideration, particularly in individuals with sensitive skin [10,19].

Potential Synergies with Other Acne Treatments

Phages may be used in combination with existing therapies to enhance outcomes [12,18,19]:

In summary, C. acnes-specific phages exhibit several characteristics host specificity, lytic activity, biofilm penetration that make them attractive candidates for acne therapy [6,12–15,18,21]. In the context of athletic populations, where microbiome preservation, rapid recovery, and formulation stability are paramount, phage-based approaches offer a theoretically superior alternative to traditional antimicrobials [2–4,10,19].

The Athlete as a Unique Dermatologic Patient

Athletes present a distinctive therapeutic challenge for dermatologists due to the intersection of high physical demands, environmental exposures, and performance requirements [2–4,10]. Skin health is not merely a cosmetic consideration—it influences comfort, equipment tolerance, thermoregulation, and, in some cases, the ability to participate in sport. Acne in athletes can be exacerbated by sport-specific factors such as prolonged equipment use, increased sebaceous activity from elevated androgen levels, and recurrent skin friction [2–4].

A therapeutic approach in this context must be targeted, rapid in onset, minimally disruptive to the microbiome [6,16], and compatible with training and competition schedules [10,11,19].

Delivery and Formulation Considerations for Athletes

Timing of Phage Therapy in the Athletic Calendar

Sport-Specific Application Scenarios

Integration with Sports Dermatology Protocols

In elite sports environments, dermatologic interventions must be harmonized with the broader sports medicine team, including physicians, physiotherapists, and nutritionists. A practical integration model could include:

Anti-Doping Considerations

Although phages themselves are not performance-enhancing, the excipients and preservatives in formulations must be scrutinized to ensure compliance with World Anti-Doping Agency (WADA) regulations. Additionally, athletes at international competition levels require documentation of therapeutic use to preempt any queries from regulatory authorities. Clear communication between dermatologists, sports medicine physicians, and anti-doping officers will be essential for smooth adoption [11].

Potential Psychological Benefits

Acne in athletes is not merely a physical concern; visible lesions can impact confidence, media image, and perceived professionalism- particularly in sports with high public exposure. Rapid, microbiome-preserving treatments like phage therapy could mitigate these effects, supporting both mental well-being and performance focus.

In sum, integrating bacteriophage therapy into sports medicine involves more than simply substituting it for antibiotics- it requires tailoring delivery systems, timing, and monitoring to the rhythms and realities of athletic life. By aligning the biological strengths of phage therapy with the practical demands of competitive sports, dermatologists can offer athletes a targeted, performance-compatible solution for C. acnes dysbiosis [10].

Challenges and Barriers to Implementation

While bacteriophage therapy holds considerable promise for managing Cutibacterium acnes dysbiosis in athletes [6,12–14,18,19,21], several scientific, regulatory, logistical, and clinical challenges remain before it can be integrated into routine sports dermatology practice. These barriers must be systematically addressed to ensure safety, efficacy, and acceptance among athletes, clinicians, and regulatory bodies [10,19].

Regulatory Complexity

Manufacturing and Quality Control

Scientific and Clinical Limitations

Adoption and Acceptance Challenges

Research Priorities to Overcome Barriers

Key areas for future research include:

In summary, the path to implementing C. acnes phage therapy in sports medicine is navigable but complex [19]. Success will depend on coordinated efforts across microbiology, dermatology, sports medicine, regulatory affairs, and athlete advocacy [10,19].

Future Directions and Research Priorities

The integration of bacteriophage therapy into acne management for athletes represents a significant departure from conventional approaches [6,12–14,18,19], shifting from broad-spectrum microbial suppression [1,9] to precision microbiome modulation [6,7,19]. While current data support the theoretical advantages of C. acnes phages [6,12–14,18], the field is still in early translational stages [19,20]. Emerging trends, technological advances, and targeted research will determine whether phage therapy becomes a mainstream component of sports dermatology [10,19].

Table 3 shows Future directions and research priorities.

Table 3: Research priorities for phage therapy in sports dermatology.

Personalized Phage Cocktails Based on Microbiome Profiling

One of the most promising avenues is the development of personalized phage formulations tailored to the strain composition of an individual athlete’s skin microbiome [5–7]. Advances in next-generation sequencing (NGS) and metagenomics now allow for rapid identification of dominant C. acnes phylotypes and their virulence gene profiles [5,6]. Coupled with a well-characterized phage library [12,14,18,21], this could enable same-week customization of treatment.

In elite sports environments, pre-season microbiome screening could become a standard practice [7,19], allowing dermatologists to preemptively address potentially pathogenic C. acnes populations before high-intensity training begins [2–6]. Such an approach could also be adapted for reactive treatment during flare-ups, with rapid diagnostic-to-therapy pipelines [7,19,20].

AI-Driven Phage–Host Interaction Prediction

Artificial intelligence (AI) and machine learning are poised to accelerate phage therapy development [18,21]. Algorithms trained on known phage–host interactions [14,21] can identify potential receptor-binding domains and resistance-associated mutations in C. acnes [5,14], informing cocktail composition without exhaustive wet-lab testing. AI-driven models could also forecast the evolutionary trajectories of both C. acnes and its phages under athletic environmental pressures—such as repeated sweat exposure [2–4], skin friction [2–4], and cleansing routines [1–4]—helping to maintain long-term efficacy [18,21].

Engineering Enhanced Phages

While naturally occurring C. acnes phages have shown therapeutic promise [12,14,18,21], synthetic biology offers opportunities to enhance their stability, activity, and specificity [18,19]. Possible engineering strategies include:

These engineered phages would still require thorough regulatory review [11,19], but advances in CRISPR-Cas and recombineering techniques have made such modifications feasible [18,19].

Combination Therapies with Microbiome Restoration

Targeting pathogenic C. acnes strains is only half the equation—rebuilding a balanced microbiome is equally important [6,16]. Future protocols for athletes could integrate phage therapy with:

These approaches may also reduce the risk of secondary infections, such as S. aureus or Malassezia overgrowth [2–4,6,16,26].

Development of Sport-Specific Phage Delivery Systems

Given the unique dermatologic stressors faced by athletes [2–4], custom delivery formats will be crucial:

Advances in nanocarriers such as lipid nanoparticles and polymeric micelles could further protect phages during application [19,20].